Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Cyclophosphamide followed BY methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 44 💬
2Glucocorticoids----10件: 35, 40, 41, 43, 44, 75, 96, 221, 222, 300 💬
3Glucocorticoids - reduced dose----2件: 43, 44 💬
4Glucocorticoids - standard dose----2件: 43, 44 💬
5Gusperimus + glucocorticoids1件: Gusperimus2件: Gusperimus trihydrochloride ,
Gusperimus 💬
--1件: 44 💬
6Intravenous glucocorticoids----1件: 13 💬
7Levamisole+cyclosporin A+glucocorticoids2件: Cyclosporine,
Levamisole
3件: Cyclosporine ,
Levamisole hydrochloride ,
Levamisole 💬
5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 60, 62 💬
8Oral glucocorticoids----1件: 13 💬